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Abstract
Se-Jin Lee was elected member to the National Academy of Sciences on 28 April 2012. Dr Lee is responsible for the
discovery of myostatin, a critical regulator of skeletal muscle mass and function. He also determined the primary
binding receptor for myostatin, and has characterized additional transforming growth factor–β family members
acting in this pathway.
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Commentary
Professor Se-Jin Lee was elected on 28 April to the Uni-
ted States National Academy of Sciences for his research
achievements, most notably the discovery of myostatin
and its role in skeletal muscle maintenance.
Dr Lee is a Professor of Molecular Biology and Genet-
ics at Johns Hopkins University. He holds an MD and
PhD, and he joined Hopkins after a period as an associ-
ate at the Carnegie Institution for Science.
His first major paper in the area that led him on his
most fruitful research path was published in Nature in
1994 [1]. In that study, Professor Lee reported on the
discovery of several transforming growth facto (TGF)-β
family members: growth differentiation factor (GDF)5, 6
and 7. Next, in 1997, Professor Lee and his co-authors
Alexandra McPherron and Ann Lawler described the
identification of myostatin, also known as GDF8, via RT-
PCR, using degenerate primers from TGF-β family
member homology domains [2]. In that same manu-
script, they described the myostatin mouse knockout,
and the dramatic skeletal muscle hypertrophy caused by
deletion of myostatin, a phenotype that still manages to
startle. A two- to three-fold increase in muscle mass was
observed in the GDF8 null muscle [2]. Later that year,
McPherron and Lee also reported that Piedmontese and
Belgian Blue cattle, notable for their hypermuscularity,
have naturally occurring disruptions of the myostatin
locus [3].
Dr Lee went on to extensively study myostatin, and in
subsequent papers demonstrated the loss of white fat
that occurs upon induction of hypermuscularity by
myostatin inhibition [4], and that administration of
myostatin was sufficient to cause a phenotype reminis-
cent of cachexia [5]. He next showed that myostatin was
regulated by a metalloprotease that activates it from a la-
tent state [6], and identified the activin receptor type IIb
receptor as one of the key receptors for myostatin [7].
This last paper highlighted an ongoing trend of first-au-
thor manuscripts for Dr Lee, a testament to his contin-
ued commitment to working at the bench.
Finally, Dr Lee has shown that other molecules in the
TGF-β pathway, notably the activins and follistatin, also
regulate muscle mass [8,9].
Dr Lee’s contributions include the demonstration of
potential therapeutic benefits for myostatin inhibition.
The precise clinical setting in which myostatin blockade
might be beneficial has not yet been finally determined
in humans, but it is at least clear that human null muta-
tions for myostatin have a similar phenotype of hyper-
muscularity [10]. One potential area for blockade of this
family of factors is cancer cachexia, as was demonstrated
with an activin receptor IIb trap [11].
Dr Lee’s election to the Academy represents great rec-
ognition both for him and for the skeletal muscle field
as a whole. His career is a testament to continued close
study of a mechanism, leading to the initiation of an en-
tirely new field of basic and biomedical research.
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